Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Public ClinicalTrials.gov record NCT00624078. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This treatment protocol will enable therapeutic use of Anascorp in the management of systemic manifestations of scorpion sting envenomation, in patients for whom antivenom would otherwise be unavailable. The working hypotheses are as follows: 1. The investigational antivenom is safe as treatment of scorpion sting envenomation. 2. The investigational antivenom is effective as treatment of scorpion sting envenomation.
Study identification
- NCT ID
- NCT00624078
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 1,426 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2005 (Type not available)
- Primary completion
- Sep 2010 (Actual)
- Completion
- Sep 2010 (Actual)
- Last update posted
- Feb 23, 2011
2005 – 2010
United States locations
- U.S. sites
- 18
- U.S. states
- 1
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Casa Grande Regional Medical Center | Casa Grande | Arizona | 85222 | — |
| Chandler Regional | Chandler | Arizona | 85224 | — |
| Southeast Arizona Medical Center | Douglas | Arizona | 85260 | — |
| Mercy Gilbert Medical Center | Gilbert | Arizona | 85297 | — |
| Banner Thunderbird Medical Center | Glendale | Arizona | 85306 | — |
| Banner Baywood Medical Center | Mesa | Arizona | 86206 | — |
| Gila Health Resources | Morenci | Arizona | 85540 | — |
| Holy Cross Hospital | Nogales | Arizona | 85621 | — |
| Maricopa Medical Center | Phoenix | Arizona | 85008 | — |
| Phoenix Children's Hospital | Phoenix | Arizona | 85016 | — |
| John C. Lincoln | Phoenix | Arizona | 85027 | — |
| Mt. Graham Regional Medical Center | Safford | Arizona | 85546 | — |
| San Carlos Indian Hospital | San Carlos | Arizona | 85550 | — |
| Scottsdale Healthcare | Scottsdale | Arizona | 85260 | — |
| Tucson Medical Center | Tucson | Arizona | 85712 | — |
| University Medical Center | Tucson | Arizona | 85724 | — |
| St. Mary's Hospital | Tucson | Arizona | 85745 | — |
| Whiteriver IHS Hospital | Whiteriver | Arizona | 85941 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00624078, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 23, 2011 · Synced Nov 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00624078 live on ClinicalTrials.gov.